Research Analysts’ price target changes for Friday, January 5th:

ABB (VTX:ABBN) was given a CHF 31 target price by analysts at Goldman Sachs Group Inc. The firm currently has a buy rating on the stock.

Allergan (NYSE:AGN) was given a $245.00 price target by analysts at Wells Fargo & Co. The firm currently has a buy rating on the stock.

Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ:APOP) was given a $14.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

AveXis (NASDAQ:AVXS) was given a $122.00 target price by analysts at UBS Group AG. The firm currently has a buy rating on the stock.

Brookfield Business Partners L.P. Limited Partnership Units (NYSE:BBU) had its target price increased by Credit Suisse Group AG to $3.15. The firm currently has an outperform rating on the stock.

Hugo Boss (ETR:BOSS) was given a €85.00 ($101.19) target price by analysts at Hauck & Aufhaeuser. The firm currently has a buy rating on the stock.

Cboe Global Markets (NASDAQ:CBOE) had its target price increased by Wells Fargo & Co from $4.75 to $138.00. The firm currently has an outperform rating on the stock.

Cerner (NASDAQ:CERN) had its price target boosted by Cantor Fitzgerald to $83.00. The firm currently has an overweight rating on the stock.

Deutsche Bank (FRA:DBK) was given a €16.00 ($19.05) target price by analysts at Royal Bank of Canada. The firm currently has a neutral rating on the stock.

Datawatch (NASDAQ:DWCH) was given a $18.00 price target by analysts at Craig Hallum. The firm currently has a buy rating on the stock.

Equity Lifestyle Properties (NYSE:ELS) was given a $90.00 price target by analysts at Robert W. Baird. The firm currently has a neutral rating on the stock.

EOG Resources (NYSE:EOG) was given a $122.00 price target by analysts at Robert W. Baird. The firm currently has a buy rating on the stock.

Fitbit (NYSE:FIT) had its price target reduced by Morgan Stanley from $7.00 to $6.00. The firm currently has an equal weight rating on the stock.

Foamix Pharmaceuticals (NASDAQ:FOMX) was given a $12.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

GrubHub (NYSE:GRUB) had its price target increased by Oppenheimer Holdings Inc.. They currently have an outperform rating on the stock.

HTG Molecular Diagnostics (NASDAQ:HTGM) was given a $6.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Immune Pharmaceuticals (NASDAQ:IMNP) was given a $3.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock. The analysts wrote, “Bertilimumab is a monoclonal antibody (mAb) targeting eotaxin-1, a chemokine implicated in multiple inflammatory diseases including bullous pemphigoid (BP) and ulcerative colitis (UC), with potential expansion to atopic dermatitis (AD) and asthma.””

Macy's (NYSE:M) had its target price raised by BMO Capital Markets from $3.63 to $38.00. They currently have an outperform rating on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by Jefferies Group LLC to $105.00. Jefferies Group LLC currently has a buy rating on the stock.

Universal Display (NASDAQ:OLED) had its target price increased by Susquehanna Bancshares Inc from $195.00 to $215.00. Susquehanna Bancshares Inc currently has a positive rating on the stock.

Park Electrochemical (NYSE:PKE) had its target price increased by Needham & Company LLC to $24.00. Needham & Company LLC currently has a buy rating on the stock. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Royal Bank of Canada (NYSE:RY) (TSE:RY) had its price target raised by Argus to $94.00. They currently have a buy rating on the stock. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Shire (NASDAQ:SHPG) was given a $225.00 target price by analysts at Cowen Inc. The firm currently has a buy rating on the stock.

UBS Group (VTX:UBSG) was given a CHF 20 price target by analysts at Royal Bank of Canada. The firm currently has a neutral rating on the stock.

United Therapeutics (NASDAQ:UTHR) had its target price boosted by Oppenheimer Holdings Inc. to $180.00. The firm currently has an outperform rating on the stock.

Valeant Pharmaceuticals Intl (NYSE:VRX) (TSE:VRX) had its target price raised by TD Securities from $20.00 to $27.00. TD Securities currently has a buy rating on the stock.

Wyndham Worldwide (NYSE:WYN) had its price target boosted by Stifel Nicolaus from $113.00 to $123.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Zalando (FRA:ZAL) was given a €43.00 ($51.19) target price by analysts at Goldman Sachs Group Inc. The firm currently has a neutral rating on the stock.

Receive News & Ratings for ABB Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABB Ltd and related companies with MarketBeat.com's FREE daily email newsletter.